Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Centers for Disease Control and Prevention (CDC) Grants for Public Health Research Dissertation, Program Announcement (PA) PAR07-231, Panel C, 54667 [E7-18947]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 186 / Wednesday, September 26, 2007 / Notices
Ethics, Suite 500, 1201 New York
Avenue, NW., Washington, DC 20005–
3917; Telephone: 202–482–9300; TDD:
202–208–9293; FAX: 202–482–9237.
5 U.S.C.
4314(c) requires each agency to
establish, in accordance with
regulations prescribed by the Office of
Personnel Management at 5 CFR part
430, subpart C and § 430.310 thereof in
particular, one or more Senior Executive
Service performance review boards. As
a small executive branch agency, OGE
has just one board. In order to ensure an
adequate level of staffing and to avoid
a constant series of recusals, the
designated members of OGE’s SES
Performance Review Board are being
drawn, as in the past, in large measure
from the ranks of other agencies. The
board shall review and evaluate the
initial appraisal of each OGE senior
executive’s performance by his or her
supervisor, along with any
recommendations in each instance to
the appointing authority relative to the
performance of the senior executive.
This revised notice updates the
membership of OGE’s SES Performance
Review Board as it was most recently
published at 72 FR 53773–53774
(September 20, 2007), in order to reflect
the appointment of one new member
from another agency to replace a
member from an agency who was not
able to serve on OGE’s board this year.
SUPPLEMENTARY INFORMATION:
Approved: September 21, 2007.
Robert I. Cusick,
Director, Office of Government Ethics.
mstockstill on PROD1PC66 with NOTICES
The following officials have been
appointed as regular members of the
SES Performance Review Board of the
Office of Government Ethics:
Marilyn L. Glynn [Chair], General
Counsel, Office of Government Ethics
Daniel D. Dunning [Alternate Chair],
Deputy Director for Administration
and Information Management, Office
of Government Ethics
Daniel L. Koffsky, Special Counsel,
Office of Legal Counsel, Department
of Justice
David Maggi, Chief, Ethics Law and
Programs Division, Office of the
Assistant General Counsel for
Administration, Department of
Commerce; and
Robert A. Shapiro, Associate Solicitor
for Legal Counsel, Department of
Labor
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Centers for
Disease Control and Prevention (CDC)
Grants for Public Health Research
Dissertation, Program Announcement
(PA) PAR07–231, Panel B
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Centers for
Disease Control and Prevention (CDC)
Grants for Public Health Research
Dissertation, Program Announcement
(PA) PAR07–231, Panel C
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 8 a.m.–4 p.m., November
15, 2007 (Closed).
Place: Crowne Plaza Buckhead, 3377
Peachtree Road, NE., Atlanta, GA 30326,
telephone 404–264–1111.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of ‘‘CDC Grants for Public Health
Research Dissertation,’’ PA PAR07–231,
Panel B.
Contact Person for More Information:
Susan B. Stanton, D.D.S., Scientific Review
Administrator, Office of the Chief Science
Officer, CDC, 1600 Clifton Road, NE.,
Mailstop D 72, Atlanta, GA 30333, Telephone
404–639–4640.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: September 20, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–18945 Filed 9–25–07; 8:45 am]
Jkt 211001
Time and Date: 8:30 a.m.–4 p.m.,
November 16, 2007 (Closed).
Place: Crowne Plaza Buckhead, 3377
Peachtree Road, NE., Atlanta, GA 30326,
telephone 404–264–1111.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of ‘‘CDC Grants for Public Health
Research Dissertation,’’ PAR07–231, Panel C.
Contact Person for More Information:
Sheree Marshall Williams, Ph.D., M.Sc.,
Scientific Review Administrator, Office of
the Chief Science Officer, CDC, 1600 Clifton
Road, NE., Mailstop D 72, Atlanta, GA 30333,
Telephone 404–639–4896.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: September 20, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–18947 Filed 9–25–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the President’s Cancer
Panel.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
BILLING CODE 6345–02–P
17:57 Sep 25, 2007
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
BILLING CODE 4163–18–P
[FR Doc. E7–18973 Filed 9–25–07; 8:45 am]
VerDate Aug<31>2005
54667
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
E:\FR\FM\26SEN1.SGM
26SEN1
]]>Agencies
[Federal Register Volume 72, Number 186 (Wednesday, September 26, 2007)]
[Notices]
[Page 54667]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-18947]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Centers for Disease Control and Prevention (CDC)
Grants for Public Health Research Dissertation, Program Announcement
(PA) PAR07-231, Panel C
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting.
Time and Date: 8:30 a.m.-4 p.m., November 16, 2007 (Closed).
Place: Crowne Plaza Buckhead, 3377 Peachtree Road, NE., Atlanta,
GA 30326, telephone 404-264-1111.
Status: The meeting will be closed to the public in accordance
with provisions set forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the review,
discussion, and evaluation of ``CDC Grants for Public Health
Research Dissertation,'' PAR07-231, Panel C.
Contact Person for More Information: Sheree Marshall Williams,
Ph.D., M.Sc., Scientific Review Administrator, Office of the Chief
Science Officer, CDC, 1600 Clifton Road, NE., Mailstop D 72,
Atlanta, GA 30333, Telephone 404-639-4896.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: September 20, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E7-18947 Filed 9-25-07; 8:45 am]
BILLING CODE 4163-18-P
